Suppr超能文献

化学官能团对聚合物诱导异相成核速率的影响。

Influence of Chemical Functionality on the Rate of Polymer-Induced Heteronucleation.

作者信息

Frank Derek S, Matzger Adam J

机构信息

Department of Chemistry and the Macromolecular Science and Engineering Program, The University of Michigan, 930 North University Avenue, Ann Arbor, Michigan 48109-1055, United States.

出版信息

Cryst Growth Des. 2017;17(8):4056-4059. doi: 10.1021/acs.cgd.7b00593. Epub 2017 Jun 23.

Abstract

Polymer-induced heteronucleation can dramatically increase the nucleation rate of pharmaceuticals. However, directly comparing the heteronucleation rates of different polymer functionalities is often convoluted with changing physical or structural aspects of heteronuclei. Here, we report a methodology for comparing nucleation efficiencies of different functionalities on polymer heteronuclei of uniform topology with the goal of identifying those functionalities that best accelerate nucleation of a model pharmaceutical. It was found that the previously employed design for additives to speed acetaminophen crystallization underperforms a modified framework that accounts for the effect of competitive solvent binding. These findings are informed by a survey of interactions from the CSD and not only serve to aid in the controlled crystallization of pharmaceuticals, but also provide insight into the mechanism of heteronucleation.

摘要

聚合物诱导的异相成核可显著提高药物的成核速率。然而,直接比较不同聚合物官能团的异相成核速率往往因异质核物理或结构方面的变化而变得复杂。在此,我们报告一种方法,用于比较具有均匀拓扑结构的聚合物异质核上不同官能团的成核效率,目的是识别那些最能加速模型药物成核的官能团。研究发现,先前用于加速对乙酰氨基酚结晶的添加剂设计不如一种改进的框架,该框架考虑了竞争性溶剂结合的影响。这些发现是基于对剑桥晶体结构数据库(CSD)中相互作用的调查得出的,不仅有助于药物的可控结晶,还能深入了解异相成核的机制。

相似文献

1
Influence of Chemical Functionality on the Rate of Polymer-Induced Heteronucleation.
Cryst Growth Des. 2017;17(8):4056-4059. doi: 10.1021/acs.cgd.7b00593. Epub 2017 Jun 23.
2
Controlling pharmaceutical crystallization with designed polymeric heteronuclei.
J Am Chem Soc. 2015 Jan 21;137(2):871-5. doi: 10.1021/ja511106j. Epub 2015 Jan 6.
3
On the mechanism of crystalline polymorph selection by polymer heteronuclei.
Langmuir. 2011 Jun 21;27(12):7575-9. doi: 10.1021/la200689a. Epub 2011 May 19.
4
Selection of Protein Crystal Forms Facilitated by Polymer-Induced Heteronucleation.
Cryst Growth Des. 2008;8(1):347-350. doi: 10.1021/cg0703745.
5
Inhibiting or Accelerating Crystallization of Pharmaceuticals by Manipulating Polymer Solubility.
Mol Pharm. 2019 Aug 5;16(8):3720-3725. doi: 10.1021/acs.molpharmaceut.9b00468. Epub 2019 Jul 8.
6
Morphology study of progesterone polymorphs prepared by polymer-induced heteronucleation (PIHn).
Scanning. 2013 Jul-Aug;35(4):213-21. doi: 10.1002/sca.21045. Epub 2012 Oct 3.
7
Crystalline polymorph selection and discovery with polymer heteronuclei.
J Am Chem Soc. 2005 Apr 20;127(15):5512-7. doi: 10.1021/ja042561m.
9
Crystallization of progesterone polymorphs using polymer-induced heteronucleation (PIHn) method.
Drug Dev Ind Pharm. 2015 May;41(5):851-8. doi: 10.3109/03639045.2014.909839. Epub 2014 Apr 24.

引用本文的文献

1
Stimuli-Responsive Star Polymer as an Admixture for Crystallization of Hollow Crystals.
Materials (Basel). 2022 Nov 20;15(22):8240. doi: 10.3390/ma15228240.
2
Application of Polymers as a Tool in Crystallization-A Review.
Polymers (Basel). 2021 Aug 12;13(16):2695. doi: 10.3390/polym13162695.
5
6
Probing the Interplay between Amorphous Solid Dispersion Stability and Polymer Functionality.
Mol Pharm. 2018 Jul 2;15(7):2714-2720. doi: 10.1021/acs.molpharmaceut.8b00219. Epub 2018 Jun 20.

本文引用的文献

1
Polymorphism in phenobarbital: discovery of a new polymorph and crystal structure of elusive form V.
Chem Commun (Camb). 2016 Mar 21;52(23):4389-92. doi: 10.1039/c6cc00959j.
2
Controlling pharmaceutical crystallization with designed polymeric heteronuclei.
J Am Chem Soc. 2015 Jan 21;137(2):871-5. doi: 10.1021/ja511106j. Epub 2015 Jan 6.
3
Morphology study of progesterone polymorphs prepared by polymer-induced heteronucleation (PIHn).
Scanning. 2013 Jul-Aug;35(4):213-21. doi: 10.1002/sca.21045. Epub 2012 Oct 3.
4
On the mechanism of crystalline polymorph selection by polymer heteronuclei.
Langmuir. 2011 Jun 21;27(12):7575-9. doi: 10.1021/la200689a. Epub 2011 May 19.
7
Unmasking a third polymorph of a benchmark crystal-structure-prediction compound.
Angew Chem Int Ed Engl. 2009;48(45):8505-8. doi: 10.1002/anie.200903285.
8
Polymorphism in Carbamazepine Cocrystals.
Cryst Growth Des. 2008;8(1):14-16. doi: 10.1021/cg701022e.
9
Molecular recognition at crystal interfaces.
Science. 1991 Aug 9;253(5020):637-45. doi: 10.1126/science.253.5020.637.
10
Crystalline polymorph selection and discovery with polymer heteronuclei.
J Am Chem Soc. 2005 Apr 20;127(15):5512-7. doi: 10.1021/ja042561m.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验